Composite lymphoma after chemotherapy with regressed diffuse large B-cell lymphoma and transformed cytotoxic T-cell lymphoma

Leukemia and Lymphoma

Volumn 54, Issue 5, 2013, Pages 1101-1104

  Dy, Janelyn A L ^a,c   Chen, Shang Wen ^b   Chang, Chia Hao ^a   Chang, Sheng Tsung ^a   Kuo, Szu Yin ^a   Ye, Hongtao ^d   Khanom, Fatheha ^e   Bandoh, Betty Nuako ^e   Liu, Hongxiang ^e   Chuang, Shih Sung ^a,f  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b Department of Internal Medicine   (Taiwan)

^c University of the East Ramon Magsaysay   (Philippines)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; MELPHALAN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

AGED; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CHILL; CHOLECYSTECTOMY; COMPOSITE LYMPHOMA; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DYSURIA; FALLING; FEBRILE NEUTROPENIA; FEVER; HEPATITIS B; HUMAN; HYPOVOLEMIC SHOCK; INTERNATIONAL PROGNOSTIC INDEX; INTESTINE HEMATOMA; LACTATE DEHYDROGENASE BLOOD LEVEL; LAPAROTOMY; LARGE CELL LYMPHOMA; LETTER; LIVER NODULE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; PANCYTOPENIA; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SPLENOMEGALY; SUBDURAL HEMATOMA; T CELL LYMPHOMA; URINARY FREQUENCY; WEIGHT REDUCTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMPOSITE LYMPHOMA; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL; MALE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84876204032     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.733876     Document Type: Letter

References (12)

1. Mokhtar NM. Review article composite lymphoma. J Egypt Natl Cancer Inst 2007;19:171-175.
2. Tirumala S, Esposito M, Fuchs A. An unusual variant of composite lymphoma: a short case report and review of the literature. Arch Pathol Lab Med 2000; 124: 1376-1378.
3. Yang SF, Chang WY, Lan CC, et al. Composite primary cutaneous peripheral T-cell lymphoma and Epstein-Barr virus-positive large B-cell lymphoma. Leuk Lymphoma 2011;52:2027-2030.
4. Ho JW, Ho FC, Chan AC, et al. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas. J Pathol 1998;185:79-85.
5. Mattoch IW, Fulton R, Kim Y, et al. Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells. Am J Clin Pathol 2009;131:810-819.
6. Higgins JP, van de Rijn M, Jones CD, et al. Peripheral T-cell lymphoma complicated by a proliferation of large B cells. Am J Clin Pathol 2000;114:236-247.
7. Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecifed. Am J Clin Pathol 2002;117:368-379.
8. Reichard KK, Schwartz EJ, Higgins JP, et al. CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells. Mod Pathol 2006;19:337-343.
9. Martinez A, Pittaluga S, Villamor N, et al. Clonal T-cell populations and increased rish for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol 2004;28:849-858.
10. Hsieh Y, Chang ST, Huang W T, et al. A comparative study of f ow cytometric T-cell receptor V β repertoire and T-cell receptor gene rearrangement in the diagnosis of large granular lymphocytic lymphoproliferation. Int J Lab Hematol 2013; Epub ahead of print [doi: 10.1111/ijlh.12041].
11. Viny A, Lichtin A, Phhlman B, et al. Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia. Leuk Lymphoma 2008;49:932-938.
12. Hirata Y, Yokote T, Kobayashi K, et al. Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecifed. Leuk Res 2009;33:e13-e16.